Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects [Phase 2]
Phase 2 study of BPN14770 in early Alzheimer's disease has completed and results were posted on 2025-02-18.
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: 11C-PIB PET Study in MESA at Columbia University
A completed clinical trial using the 11C-PIB PET tracer in the MESA cohort at Columbia University to study cognitive impairment and vascular…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits
This clinical trial update presents long-term follow-up data on cognitive and functional evolution in people with isolated cognitive complai…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating AC Immune's tau-targeted vaccine in early Alzheimer's disease has completed and posted results, assess…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: A Practical Platform for In-Home Remote Monitoring of Cognitive Frailty
The document reports the completion of a clinical trial evaluating a practical in-home platform for remote monitoring of cognitive frailty.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems [NA]
This update reports the completion of a pilot pragmatic clinical trial at UConn Health evaluating embedding tele-savvy approaches into healt…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Probiotics in Dementia [NA]
A completed clinical trial evaluated probiotics for dementia, including Alzheimer's disease, sponsored by Medical University of Graz.
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Home Test for Measuring Plasma P-tau217 in Alzheimer's Disease [NA]
The trial evaluating a home test for measuring plasma p-tau217 in Alzheimer's disease was terminated; the study enrolled individuals with Al…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Monitoring Anti-Dementia Drugs by Serum Levels [Phase 4]
Phase 4 trial update evaluating serum-level monitoring for anti-dementia drugs in dementia patients, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Assessing a Novel Virtual Environment That Assists With Activities of Daily Living [NA]
A completed clinical trial evaluating a novel virtual environment intended to help individuals with dementia and Alzheimer's disease perform…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: A Phase 1 Study of VG-3927 in Healthy Adults and Patients With Alzheimer's Disease [Phase 1]
A Phase 1 clinical trial of VG-3927 conducted in healthy adults and patients with Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)
This completed study describes a method to identify patients who are highly likely to meet eligibility criteria for an Alzheimer's disease c…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation [Phase 2, Phase 3]
The Dominantly Inherited Alzheimer Network Trial, studying potential disease-modifying treatments for individuals at risk for or with famili…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: STAR Caregivers - Virtual Training and Follow-up [NA]
Results from the STAR Caregivers virtual training and follow-up trial in Alzheimer's disease and dementia have been completed with results p…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD [Phase 2]
Phase 2 study evaluating the safety and immunogenicity of repeated doses of ABvac40 in adults with Mild Cognitive Impairment or Alzheimer Di…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease [Phase 1]
Alzinova's ALZ-101 Phase 1 trial in early Alzheimer's disease completed, assessing safety, tolerability, and immunogenicity. The study provi…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Effect of Food and Age on the Pharmacokinetics of LY03017 [Phase 1]
This update describes a Phase 1 pharmacokinetic study of LY03017 evaluating the effects of food and age on its pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update reporting results for CST-2032 and CST-107 in individuals with mild cognitive impairment or mild dementia due …
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Dynamic Response to Probiotics in Context of Alzheimer Disease: a Proof-of-concept Study [NA]
Completed proof-of-concept trial evaluating the impact of probiotics on outcomes in Alzheimer’s disease.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment
Completed clinical and genetic study of neurodegenerative disorders with cognitive impairment, highlighting Alzheimer's disease and dementia…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly Volunteers [Phase 1, Phase 2]
Actinogen Medical completed a Phase 1/2 double-blind, placebo-controlled, dose-ranging trial of Xanamem in healthy elderly volunteers, with …
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of NanoLithium NP03 in patients with mild-to-severe Alzheimer's disease has comple…
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Targeting Default Mode Network Dysfunction in Persons At Risk of Alzheimer's Disease with Non-invasive Techniques [NA]
A completed clinical trial evaluating non-invasive methods to target default mode network dysfunction in people at risk for Alzheimer's dise…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Tablet-based Cognitive Training [NA]
A clinical trial update for a tablet-based cognitive training program targeting Alzheimer's disease, dementia, and mild cognitive impairment…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Transmagnetic Stimulation Pilot in Early Stage Alzheimer's Disease [NA]
Completed pilot trial evaluating transmagnetic stimulation for early-stage Alzheimer disease; results posted 2025-01-07.